Edgen Stock·Dec 11 2025, 21:09Back
Roivant Sciences Stock Gains 5.41%
Edgen Stock·Dec 11 2025, 21:09
[1] Avant Technologies and Austrianova Advancing α-Klotho Cell Therapy as Mayo Clinic Study Links Low α-Klotho Levels to Poor Cardiovascular Survival - BioSpace (https://www.biospace.com/press-releases/avant ...)[2] D3 Bio Secures $108 Million in Series B Financing to Advance Global Clinical Programs - BioSpace (https://www.biospace.com/press-releases/d3-bi ...)[3] Phanes Therapeutics to Present Phase 1/2 Study Results of Spevatamig (PT886) in Combination with Chemotherapy in Frontline (1L) Treatment of Metastatic PDAC at ASCO GI 2026 - BioSpace (https://www.biospace.com/press-releases/phane ...)
